O75815 (BCAR3_HUMAN) Reviewed, UniProtKB/Swiss-Prot
Last modified
May 1, 2013.
Version 106.
History...
Names·Attributes·General annotation·Ontologies·Alt products·Sequence annotation·Sequences·References·Cross-refs·Entry info·DocumentsCustomize order
Names·Attributes·General annotation·Ontologies·Alt products·Sequence annotation·Sequences·References·Cross-refs·Entry info·DocumentsCustomize orderNames and origin
| Protein names | Recommended name: Breast cancer anti-estrogen resistance protein 3 Alternative name(s): Novel SH2-containing protein 2 SH2 domain-containing protein 3B | ||||||
| Gene names |
| ||||||
| Organism | Homo sapiens (Human) [Reference proteome] | ||||||
| Taxonomic identifier | 9606 [NCBI] | ||||||
| Taxonomic lineage | Eukaryota › Metazoa › Chordata › Craniata › Vertebrata › Euteleostomi › Mammalia › Eutheria › Euarchontoglires › Primates › Haplorrhini › Catarrhini › Hominidae › Homo![]() |
Protein attributes
| Sequence length | 825 AA. |
| Sequence status | Complete. |
| Protein existence | Evidence at protein level |
General annotation (Comments)
| Function | May act as an adapter protein and couple activated growth factor receptors to a signaling pathway that regulates the proliferation in breast cancer cells. When overexpressed, it confers anti-estrogen resistance in breast cancer cell lines. May also be regulated by cellular adhesion to extracellular matrix proteins. Ref.1 |
| Subunit structure | Interacts with BCAR1, NEDD9, PTK2/FAK1 and PTPN1 By similarity. |
| Tissue specificity | Ubiquitously expressed. Found in several cancer cell lines, but not in nonmalignant breast tissue. Ref.1 Ref.2 |
| Sequence similarities | Contains 1 Ras-GEF domain. Contains 1 SH2 domain. |
Ontologies
| Keywords | |
|---|---|
| Coding sequence diversity | Alternative splicing Polymorphism |
| Domain | SH2 domain |
| Molecular function | Guanine-nucleotide releasing factor |
| PTM | Phosphoprotein |
| Technical term | 3D-structure Complete proteome Reference proteome |
| Gene Ontology (GO) | |
| Biological_process | response to drug Traceable author statement Ref.1. Source: ProtInc signal transductionTraceable author statement Ref.1. Source: ProtInc small GTPase mediated signal transductionInferred from electronic annotation. Source: InterPro |
| Cellular_component | intracellular Inferred from electronic annotation. Source: InterPro |
| Molecular_function | guanyl-nucleotide exchange factor activity Inferred from electronic annotation. Source: UniProtKB-KW |
| Complete GO annotation... | |
Alternative products
| This entry describes 2 isoforms produced by alternative splicing. [Align] [Select] | ||||||
| Isoform 1 (identifier: O75815-1) This isoform has been chosen as the 'canonical' sequence. All positional information in this entry refers to it. This is also the sequence that appears in the downloadable versions of the entry. | ||||||
| Isoform 2 (identifier: O75815-2) The sequence of this isoform differs from the canonical sequence as follows: 1-324: Missing. | ||||||
| Note: No experimental confirmation available. |
Sequence annotation (Features)
| Feature key | Position(s) | Length | Description | Graphical view | Feature identifier | |||||||||||||||||||||||||||||||||||||||||||||||||
Molecule processing | ||||||||||||||||||||||||||||||||||||||||||||||||||||||
|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|
| Chain | 1 – 825 | 825 | Breast cancer anti-estrogen resistance protein 3 | PRO_0000230284 | ||||||||||||||||||||||||||||||||||||||||||||||||||
Regions | ||||||||||||||||||||||||||||||||||||||||||||||||||||||
| Domain | 154 – 253 | 100 | SH2 | |||||||||||||||||||||||||||||||||||||||||||||||||||
| Domain | 548 – 818 | 271 | Ras-GEF | |||||||||||||||||||||||||||||||||||||||||||||||||||
| Compositional bias | 479 – 482 | 4 | Poly-Asp | |||||||||||||||||||||||||||||||||||||||||||||||||||
Amino acid modifications | ||||||||||||||||||||||||||||||||||||||||||||||||||||||
| Modified residue | 32 | 1 | Phosphoserine Ref.8 | |||||||||||||||||||||||||||||||||||||||||||||||||||
| Modified residue | 83 | 1 | Phosphoserine Ref.8 | |||||||||||||||||||||||||||||||||||||||||||||||||||
| Modified residue | 182 | 1 | Phosphoserine Ref.7 | |||||||||||||||||||||||||||||||||||||||||||||||||||
| Modified residue | 290 | 1 | Phosphoserine Ref.8 | |||||||||||||||||||||||||||||||||||||||||||||||||||
| Modified residue | 358 | 1 | Phosphoserine Ref.8 | |||||||||||||||||||||||||||||||||||||||||||||||||||
| Modified residue | 363 | 1 | Phosphoserine Ref.8 | |||||||||||||||||||||||||||||||||||||||||||||||||||
| Modified residue | 370 | 1 | Phosphoserine By similarity | |||||||||||||||||||||||||||||||||||||||||||||||||||
| Modified residue | 375 | 1 | Phosphoserine Ref.7 Ref.8 | |||||||||||||||||||||||||||||||||||||||||||||||||||
Natural variations | ||||||||||||||||||||||||||||||||||||||||||||||||||||||
| Alternative sequence | 1 – 324 | 324 | Missing in isoform 2. | VSP_017814 | ||||||||||||||||||||||||||||||||||||||||||||||||||
| Natural variant | 464 | 1 | E → G. Corresponds to variant rs12062278 [ dbSNP | Ensembl ]. | VAR_050689 | ||||||||||||||||||||||||||||||||||||||||||||||||||
| Natural variant | 593 | 1 | Q → H. Corresponds to variant rs17110107 [ dbSNP | Ensembl ]. | VAR_050690 | ||||||||||||||||||||||||||||||||||||||||||||||||||
Secondary structure | ||||||||||||||||||||||||||||||||||||||||||||||||||||||
Helix Strand Turn | ||||||||||||||||||||||||||||||||||||||||||||||||||||||
| Helix | 517 – 519 | 3 | ||||||||||||||||||||||||||||||||||||||||||||||||||||
| Helix | 534 – 546 | 13 | ||||||||||||||||||||||||||||||||||||||||||||||||||||
| Helix | 549 – 563 | 15 | ||||||||||||||||||||||||||||||||||||||||||||||||||||
| Helix | 571 – 577 | 7 | ||||||||||||||||||||||||||||||||||||||||||||||||||||
| Beta strand | 578 – 580 | 3 | ||||||||||||||||||||||||||||||||||||||||||||||||||||
| Helix | 582 – 585 | 4 | ||||||||||||||||||||||||||||||||||||||||||||||||||||
| Helix | 589 – 591 | 3 | ||||||||||||||||||||||||||||||||||||||||||||||||||||
| Helix | 592 – 614 | 23 | ||||||||||||||||||||||||||||||||||||||||||||||||||||
| Helix | 620 – 639 | 20 | ||||||||||||||||||||||||||||||||||||||||||||||||||||
| Helix | 644 – 655 | 12 | ||||||||||||||||||||||||||||||||||||||||||||||||||||
| Helix | 657 – 660 | 4 | ||||||||||||||||||||||||||||||||||||||||||||||||||||
| Helix | 663 – 672 | 10 | ||||||||||||||||||||||||||||||||||||||||||||||||||||
| Helix | 674 – 682 | 9 | ||||||||||||||||||||||||||||||||||||||||||||||||||||
| Helix | 684 – 692 | 9 | ||||||||||||||||||||||||||||||||||||||||||||||||||||
| Helix | 696 – 698 | 3 | ||||||||||||||||||||||||||||||||||||||||||||||||||||
| Helix | 711 – 717 | 7 | ||||||||||||||||||||||||||||||||||||||||||||||||||||
| Helix | 724 – 726 | 3 | ||||||||||||||||||||||||||||||||||||||||||||||||||||
| Helix | 732 – 734 | 3 | ||||||||||||||||||||||||||||||||||||||||||||||||||||
| Helix | 737 – 752 | 16 | ||||||||||||||||||||||||||||||||||||||||||||||||||||
| Helix | 754 – 764 | 11 | ||||||||||||||||||||||||||||||||||||||||||||||||||||
| Turn | 765 – 767 | 3 | ||||||||||||||||||||||||||||||||||||||||||||||||||||
| Helix | 772 – 777 | 6 | ||||||||||||||||||||||||||||||||||||||||||||||||||||
| Helix | 780 – 792 | 13 | ||||||||||||||||||||||||||||||||||||||||||||||||||||
| Helix | 797 – 815 | 19 | ||||||||||||||||||||||||||||||||||||||||||||||||||||
Sequences
| ||||||||||||||||||||||||
References
| « Hide 'large scale' references | |
| [1] | "Identification of BCAR3 by a random search for genes involved in antiestrogen resistance of human breast cancer cells." van Agthoven T., van Agthoven T.L.A., Dekker A., van der Spek P.J., Vreede L., Dorssers L.C.J. EMBO J. 17:2799-2808(1998) [PubMed] [Europe PMC] [Abstract] Cited for: NUCLEOTIDE SEQUENCE [MRNA] (ISOFORM 1), TISSUE SPECIFICITY, FUNCTION. Tissue: Testis. |
| [2] | "NSP1 defines a novel family of adaptor proteins linking integrin and tyrosine kinase receptors to the c-Jun N-terminal kinase/stress-activated protein kinase signaling pathway." Lu Y., Brush J., Stewart T.A. J. Biol. Chem. 274:10047-10052(1999) [PubMed] [Europe PMC] [Abstract] Cited for: NUCLEOTIDE SEQUENCE [MRNA] (ISOFORM 1), TISSUE SPECIFICITY. Tissue: Kidney. |
| [3] | "The secreted protein discovery initiative (SPDI), a large-scale effort to identify novel human secreted and transmembrane proteins: a bioinformatics assessment." Clark H.F., Gurney A.L., Abaya E., Baker K., Baldwin D.T., Brush J., Chen J., Chow B., Chui C., Crowley C., Currell B., Deuel B., Dowd P., Eaton D., Foster J.S., Grimaldi C., Gu Q., Hass P.E. Gray A.M.Genome Res. 13:2265-2270(2003) [PubMed] [Europe PMC] [Abstract] Cited for: NUCLEOTIDE SEQUENCE [LARGE SCALE MRNA] (ISOFORM 2). |
| [4] | "The DNA sequence and biological annotation of human chromosome 1." Gregory S.G., Barlow K.F., McLay K.E., Kaul R., Swarbreck D., Dunham A., Scott C.E., Howe K.L., Woodfine K., Spencer C.C.A., Jones M.C., Gillson C., Searle S., Zhou Y., Kokocinski F., McDonald L., Evans R., Phillips K. Bentley D.R.Nature 441:315-321(2006) [PubMed] [Europe PMC] [Abstract] Cited for: NUCLEOTIDE SEQUENCE [LARGE SCALE GENOMIC DNA]. |
| [5] | Mural R.J., Istrail S., Sutton G.G., Florea L., Halpern A.L., Mobarry C.M., Lippert R., Walenz B., Shatkay H., Dew I., Miller J.R., Flanigan M.J., Edwards N.J., Bolanos R., Fasulo D., Halldorsson B.V., Hannenhalli S., Turner R. Venter J.C.Submitted (SEP-2005) to the EMBL/GenBank/DDBJ databases Cited for: NUCLEOTIDE SEQUENCE [LARGE SCALE GENOMIC DNA]. |
| [6] | "The status, quality, and expansion of the NIH full-length cDNA project: the Mammalian Gene Collection (MGC)." The MGC Project Team Genome Res. 14:2121-2127(2004) [PubMed] [Europe PMC] [Abstract] Cited for: NUCLEOTIDE SEQUENCE [LARGE SCALE MRNA] (ISOFORM 1). Tissue: Lung. |
| [7] | "A probability-based approach for high-throughput protein phosphorylation analysis and site localization." Beausoleil S.A., Villen J., Gerber S.A., Rush J., Gygi S.P. Nat. Biotechnol. 24:1285-1292(2006) [PubMed] [Europe PMC] [Abstract] Cited for: PHOSPHORYLATION [LARGE SCALE ANALYSIS] AT SER-182 AND SER-375, MASS SPECTROMETRY. Tissue: Cervix carcinoma. |
| [8] | "A quantitative atlas of mitotic phosphorylation." Dephoure N., Zhou C., Villen J., Beausoleil S.A., Bakalarski C.E., Elledge S.J., Gygi S.P. Proc. Natl. Acad. Sci. U.S.A. 105:10762-10767(2008) [PubMed] [Europe PMC] [Abstract] Cited for: PHOSPHORYLATION [LARGE SCALE ANALYSIS] AT SER-32; SER-83; SER-290; SER-358; SER-363 AND SER-375, MASS SPECTROMETRY. Tissue: Cervix carcinoma. |
| [9] | "Quantitative phosphoproteomic analysis of T cell receptor signaling reveals system-wide modulation of protein-protein interactions." Mayya V., Lundgren D.H., Hwang S.-I., Rezaul K., Wu L., Eng J.K., Rodionov V., Han D.K. Sci. Signal. 2:RA46-RA46(2009) [PubMed] [Europe PMC] [Abstract] Cited for: IDENTIFICATION BY MASS SPECTROMETRY [LARGE SCALE ANALYSIS]. Tissue: Leukemic T-cell. |
| [10] | "Quantitative phosphoproteomics reveals widespread full phosphorylation site occupancy during mitosis." Olsen J.V., Vermeulen M., Santamaria A., Kumar C., Miller M.L., Jensen L.J., Gnad F., Cox J., Jensen T.S., Nigg E.A., Brunak S., Mann M. Sci. Signal. 3:RA3-RA3(2010) [PubMed] [Europe PMC] [Abstract] Cited for: IDENTIFICATION BY MASS SPECTROMETRY [LARGE SCALE ANALYSIS]. Tissue: Cervix carcinoma. |
| + | Additional computationally mapped references. |
Cross-references
Sequence databases | |||||||||||||
|---|---|---|---|---|---|---|---|---|---|---|---|---|---|
| EMBL GenBank DDBJ | U92715 mRNA. Translation: AAC39777.1. AF124250 mRNA. Translation: AAD28245.1. AY358996 mRNA. Translation: AAQ89355.1. AL359820, AL109613 Genomic DNA. Translation: CAH73975.1. AL109613, AL359820 Genomic DNA. Translation: CAI18950.1. CH471097 Genomic DNA. Translation: EAW73065.1. CH471097 Genomic DNA. Translation: EAW73066.1. BC039895 mRNA. Translation: AAH39895.1. | ||||||||||||
| IPI | IPI00179053. IPI01009616. | ||||||||||||
| RefSeq | NP_001248337.1. NM_001261408.1. NP_001248338.1. NM_001261409.1. NP_003558.1. NM_003567.3. | ||||||||||||
| UniGene | Hs.36958. | ||||||||||||
3D structure databases | |||||||||||||
| PDBe RCSB PDB PDBj |
| ||||||||||||
| ProteinModelPortal | O75815. | ||||||||||||
| ModBase | Search... | ||||||||||||
Protein-protein interaction databases | |||||||||||||
| DIP | DIP-33857N. | ||||||||||||
| IntAct | O75815. 3 interactions. | ||||||||||||
| STRING | 9606.ENSP00000260502. | ||||||||||||
PTM databases | |||||||||||||
| PhosphoSite | O75815. | ||||||||||||
Proteomic databases | |||||||||||||
| PaxDb | O75815. | ||||||||||||
| PRIDE | O75815. | ||||||||||||
Protocols and materials databases | |||||||||||||
| DNASU | 8412. | ||||||||||||
| StructuralBiologyKnowledgebase | Search... | ||||||||||||
Genome annotation databases | |||||||||||||
| Ensembl | ENST00000260502; ENSP00000260502; ENSG00000137936. ENST00000370243; ENSP00000359263; ENSG00000137936. ENST00000370244; ENSP00000359264; ENSG00000137936. ENST00000539242; ENSP00000441343; ENSG00000137936. | ||||||||||||
| GeneID | 8412. | ||||||||||||
| KEGG | hsa:8412. | ||||||||||||
| UCSC | uc001dpx.4. human. uc009wdm.1. human. | ||||||||||||
Organism-specific databases | |||||||||||||
| CTD | 8412. | ||||||||||||
| GeneCards | GC01M094027. | ||||||||||||
| HGNC | HGNC:973. BCAR3. | ||||||||||||
| HPA | HPA014858. | ||||||||||||
| MIM | 604704. gene. | ||||||||||||
| neXtProt | NX_O75815. | ||||||||||||
| PharmGKB | PA25283. | ||||||||||||
| GenAtlas | Search... | ||||||||||||
Phylogenomic databases | |||||||||||||
| eggNOG | NOG149796. | ||||||||||||
| HOGENOM | HOG000231595. | ||||||||||||
| HOVERGEN | HBG053174. | ||||||||||||
| InParanoid | O75815. | ||||||||||||
| OMA | ERHNTMA. | ||||||||||||
| PhylomeDB | O75815. | ||||||||||||
Gene expression databases | |||||||||||||
| ArrayExpress | O75815. | ||||||||||||
| Bgee | O75815. | ||||||||||||
| CleanEx | HS_BCAR3. | ||||||||||||
| Genevestigator | O75815. | ||||||||||||
| GermOnline | ENSG00000137936. Homo sapiens. | ||||||||||||
Family and domain databases | |||||||||||||
| Gene3D | 1.10.840.10. 1 hit. 3.30.505.10. 1 hit. | ||||||||||||
| InterPro | IPR023578. Ras_GEF_dom. IPR001895. RasGRF_CDC25. IPR000980. SH2. [Graphical view] | ||||||||||||
| Pfam | PF00617. RasGEF. 1 hit. PF00017. SH2. 1 hit. [Graphical view] | ||||||||||||
| SMART | SM00147. RasGEF. 1 hit. SM00252. SH2. 1 hit. [Graphical view] | ||||||||||||
| SUPFAM | SSF48366. Ras_GEF. 1 hit. | ||||||||||||
| PROSITE | PS00720. RASGEF. False negative. PS50009. RASGEF_CAT. 1 hit. PS50001. SH2. 1 hit. [Graphical view] | ||||||||||||
| ProtoNet | Search... | ||||||||||||
Other | |||||||||||||
| ChEMBL | CHEMBL3177. | ||||||||||||
| ChiTaRS | BCAR3. human. | ||||||||||||
| GenomeRNAi | 8412. | ||||||||||||
| NextBio | 31494. | ||||||||||||
| SOURCE | Search... | ||||||||||||
Entry information
| Entry name | BCAR3_HUMAN | ||||||||
| Accession | Primary (citable) accession number: O75815 Secondary accession number(s): D3DT43, Q6UW40, Q9BR50 | ||||||||
| Entry history |
| ||||||||
| Entry status | Reviewed (UniProtKB/Swiss-Prot) | ||||||||
| Annotation program | Chordata Protein Annotation Program | ||||||||
| Disclaimer | Any medical or genetic information present in this entry is provided for research, educational and informational purposes only. It is not in any way intended to be used as a substitute for professional medical advice, diagnosis, treatment or care. | ||||||||
Relevant documents
| Human chromosome 1 Human chromosome 1: entries, gene names and cross-references to MIM |
| Human entries with polymorphisms or disease mutations List of human entries with polymorphisms or disease mutations |
| Human polymorphisms and disease mutations Index of human polymorphisms and disease mutations |
| MIM cross-references Online Mendelian Inheritance in Man (MIM) cross-references in UniProtKB/Swiss-Prot |
| PDB cross-references Index of Protein Data Bank (PDB) cross-references |
| SIMILARITY comments Index of protein domains and families |

Clusters with
